Ligand Pharmaceuticals reported $43.56M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Amgen USD 2.26B 1.34B Jun/2025
Arrowhead Research USD -165550000 546.75M Jun/2025
Baxter International USD 272M 120M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Gilead Sciences USD 2.7B 189M Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
Glaxosmithkline GBP 2.07B 237.99M Jun/2025
Insmed USD -253876000 5.74M Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
Ligand Pharmaceuticals USD 43.56M 92.88M Jun/2025
MacroGenics USD -35344000 17.49M Jun/2025
Merck USD 6.36B 149M Jun/2025
Pacira USD 10.23M 2.21M Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Veracyte USD 14.31M 11.41M Jun/2025